SCHEMBL4045470

SCHEMBL4045470

CN(C)C1(Cc2ccc(Cl)cc2)CCC(NC(=O)CCC(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 2/20 0.48
TP53 P04637 1/20 0.48
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 1/20 0.44
LMNA P02545 1/20 0.43
AVPR1A P37288 3/20 0.42
OXTR P30559 1/20 0.42
DRD3 P35462 3/20 0.41
DRD2 P14416 3/20 0.41
DRD4 P21917 2/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16143615 1.00 ACKR3 (0.48) ACKR3TP53ALDH1A1MEN1KMT2A
SCHEMBL4049886 0.91 MAPT (0.45) MEN1KMT2AMAPTLMNA
SCHEMBL4054571 0.91 ACKR3 (0.49) ACKR3ALDH1A1MEN1KMT2ADRD2
SCHEMBL4054730 0.90 ACKR3 (0.50) ACKR3ALDH1A1MEN1KMT2A
SCHEMBL4056032 0.90 CCR2 (0.46) MEN1KMT2AMAPTLMNA
SCHEMBL4048579 0.90 KMT2A (0.47) ACKR3ALDH1A1MEN1KMT2A
SCHEMBL4048483 0.89 SIGMAR1 (0.48) ACKR3TP53ALDH1A1MEN1KMT2A
SCHEMBL16143480 0.89 SIGMAR1 (0.42) ACKR3TP53ALDH1A1MEN1KMT2A
SCHEMBL4052294 0.85 ACKR3 (0.48) ACKR3ALDH1A1MEN1KMT2A
SCHEMBL4216689 0.85 SIGMAR1 (0.39) ACKR3TP53ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751088-B1 OXO-SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-10-08 EP claimed
US-7476763-B2 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2009-01-13 US claimed
US-20070088034-A1 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-04-19 US claimed
EP-1751088-B1 OXO-SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-10-08 EP disclosed
US-7476763-B2 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2009-01-13 US disclosed
US-20070088034-A1 Oxo-substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088034-A1 Oxo-substituted cyclohexyl-1,4-diamine compounds AOC1, ODC1, OTC ACKR3 3574/4885TP53 3806/4885ALDH1A1 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.